Skip to main content

Non-Small Cell Lung Cancer Specialty Channel

Featured Article
Osimertinib is associated with improved patient outcomes, global health status, quality of life, and longer time to deterioration in patients with…
A model has been developed to accurately predict the efficacy and survival outcomes of pemetrexed plus platinum doublet chemotherapy.
This interactive feature will test your knowledge about the latest research in non-small cell lung cancer.
Expert Insights
Expert-reviewed information summary about the treatment of small cell lung cancer.
Expert-reviewed information summary about the treatment of non-small cell lung cancer.
Interactive Features
This interactive feature will test your knowledge about the latest research in non-small cell lung cancer.